| J0897 | Injection, denosumab, 1 mg | 16,560 | $20 | $298.1K |
| 52442 | In this add–on procedure, the provider uses a cystourethroscope to place an additional permanent adjustable transprostatic implant to retract prostatic lobes that obstruct the urethra. | 220 | $760 | $165.5K |
| J1952 | Leuprolide injectable, camcevi, 1 mg | 1,930 | $70 | $127.6K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 21,200 | $10 | $106K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 1,390 | $70 | $90.4K |
| 52441 | Using a cystourethroscope, the provider places a single permanent adjustable transprostatic implant to retract prostatic lobes that obstruct the urethra. | 50 | $1,100 | $59.1K |
| 52000 | In this procedure, the provider performs an examination of the interior of the bladder, the urethra, and the ureteric openings by means of a cystourethroscope, a thin flexible or rigid tube with a… | 240 | $190 | $46.6K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 430 | $100 | $42.1K |
| 52287 | The provider performs an examination of the interior of the bladder, the urethra, and the ureteric openings by means of a cystoscope. He then inserts a needle and injects a neurolytic drug into the… | 110 | $320 | $33.4K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 240 | $110 | $25.4K |